Susquehanna International Group
CRBU icon

Susquehanna International Group’s Caribou Biosciences CRBU Stock Holding History

Susquehanna International Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Sell
165,414
-671,489
-80% -$1.33M ﹤0.01% 11110
2026
Q1 		$1.59M Sell
836,903
-194,472
-19% -$334K ﹤0.01% 6711
2025
Q4 		$1.64M Buy
1,031,375
+585,768
+131% +$1.23M ﹤0.01% 6052
2025
Q3 		$1.04M Buy
445,607
+180,972
+68% +$342K ﹤0.01% 7279
2025
Q2 		$333K Buy
264,635
+62,386
+31% +$61.4K ﹤0.01% 10098
2025
Q1 		$185K Buy
202,249
+83,984
+71% +$109K ﹤0.01% 11021
2024
Q4 		$188K Buy
+118,265
New +$238K ﹤0.01% 10792
2024
Q3 		– Sell
-63,550
Closed -$104K – 12115
2024
Q2 		$104K Sell
63,550
-36,404
-36% -$116K ﹤0.01% 11003
2024
Q1 		$514K Sell
99,954
-17,652
-15% -$109K ﹤0.01% 8447
2023
Q4 		$674K Sell
117,606
-42,732
-27% -$211K ﹤0.01% 7937
2023
Q3 		$766K Buy
160,338
+33,017
+26% +$205K ﹤0.01% 7242
2023
Q2 		$541K Sell
127,321
-1,610
-1% -$7.23K ﹤0.01% 8127
2023
Q1 		$685K Buy
128,931
+111,139
+625% +$692K ﹤0.01% 7782
2022
Q4 		$112K Sell
17,792
-35,802
-67% -$319K ﹤0.01% 10856
2022
Q3 		$565K Buy
53,594
+43,334
+422% +$404K ﹤0.01% 8165
2022
Q2 		$56K Sell
10,260
-14,970
-59% -$114K ﹤0.01% 11915
2022
Q1 		$232K Buy
25,230
+10,767
+74% +$113K ﹤0.01% 10879
2021
Q4 		$218K Buy
+14,463
New +$281K ﹤0.01% 11253

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group's CRBU Position: Q2 2026 in Review

Susquehanna International Group reduced its Caribou Biosciences (CRBU) stake by 80% in Q2 2026, selling an estimated $1.33M and leaving 165,414 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #11110.

Susquehanna International Group first reported a position in CRBU in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.64M in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Susquehanna International Group held 165,414 shares of Caribou Biosciences worth $291K as of Q2 2026.
  • Susquehanna International Group sold 671,489 Caribou Biosciences shares in Q2 2026, an estimated $1.33M.
  • Caribou Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #11110 holding.
  • Susquehanna International Group first reported a position in Caribou Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's Caribou Biosciences position peaked at $1.64M in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.